Molex agrees to acquire Vectura Group Limited

Molex, through its affiliate Molex Asia Holdings, signed an agreement to purchase Vectura Group Limited from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International, to expand its drug delivery capabilities in inhalation.

“Combining the strengths of Phillips Medisize and Vectura will enhance our ability to deliver a broader portfolio of inhalation combination drug devices and solutions to our pharmaceutical customers.”drug-dev.com

• 2 sources
• drug-dev.comMolex Announces Agreement to Acquire the Vectura Group Limited, Expanding its Drug Delivery Capabilities in InhalationDan MarinoSep 17, 2024
• news.outsourceaccelerator.comMolex expands drug delivery with Vectura Group acquisition - Outsource AcceleratorLiezel OnceSep 23, 2024

Summarized from public sources; check the original articles before acting on it.